5.98
+0.088(+1.49%)
Currency In EUR
Address
Germany
Phone
N/A
Website
N/A
Sector
Financial Services
Industry
Asset Management
Employees
N/A
First IPO Date
November 24, 2017
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.